9,768
Views
6
CrossRef citations to date
0
Altmetric
Case Report

Death from a possible anaphylactic reaction to ecstasy

Page 156 | Received 01 Dec 2006, Accepted 02 Mar 2007, Published online: 20 Jan 2009

Abstract

Ecstasy (3,4 methylenedioxymethamphetamine, or MDMA) is a recreational drug widely used among young people in discos or rave parties (CitationCitation). MDMA is taken because it gives a feeling of euphoria, enhances energy and sociability, and heightens sensations and sexual arousal. However, several side effects have been described: headache, nausea, anorexia, xerostomia, insomnia, myalgia, trismus, and bruxism (CitationCitation). More serious complications have also been reported, sometimes even leading to death: hyperthermia, disseminated intravascular coagulopathy, rhabdomyolysis, acute renal failure, liver failure, and water intoxication (CitationCitation). We report the unusual case of a death due to an apparent allergic reaction following ecstasy ingestion.

A healthy 13-year-old girl was partying with some school friends and her older boyfriend. The latter, a known ecstasy dealer, gave each girl one and a half tablets of ecstasy. While the other girls remained well, the victim started complaining of nausea and took an antiemetic containing zingerone. Still, she vomited and finally became apneic about four hours after the ecstasy ingestion. When emergency services arrived, she was comatose (Glasgow Coma Scale 3/15), hypothermic (33°C), hypotensive (85/67 mmHg), and tachycardic (120 beats/minute). She was first intubated with a combitube by the paramedics and then with a #7 tube in the emergency department; there was no mention of the easiness or difficulty of intubation in the medical record. Despite medical treatment, she was declared brain dead about 30 hours after the ecstasy ingestion. At autopsy, there was massive brain edema (1420g) with both tonsillar and transtentorial herniations, along with anoxic/ischemic encephalopathy. Lungs were heavy and congested (right: 560g; left: 420g). Laryngeal edema was also noted. Toxicological analyses revealed presence of zingerone in the urine and MDMA in the blood. The MDMA blood concentrations taken at hospital arrival (<0.05 mg/dL) and during autopsy were too low to explain death by acute toxicity alone. Other concomitant intoxication by alcohol or another drug was also excluded. Furthermore, biochemical analyses during hospitalization as well as autopsy findings were not consistent with disseminated intravascular coagulopathy, rhabdomyolysis, hyponatremia, acute renal or liver failure, and water intoxication. On the other hand, it is interesting to note that the victim's test results showed increased neutrophils (16.2 ¥ 109/L [reference range 1.4 to 6.5 × 109/L]). It was later found that the victim had taken ecstasy for the first time a few weeks before her death. On this first experience, her family and friends reported that she suffered from swelling of the lips. This interesting observation, in association with the laryngeal swelling noted at autopsy and the increased neutrophil count, was considered highly suggestive of an allergic reaction to ecstasy.

A multidisciplinary team of forensic pathologists and toxicologists along with emergency physicians re-evaluated the case and concluded that an anaphylactic reaction to ingestion of an ecstasy tablet was the most probable cause of death. However, it is not possible to determine if the reaction was induced by MDMA per se or by an adulterant. This is the first reported case of a possible anaphylactic reaction to MDMA, despite the large number of MDMA users. There are no reported cases of anaphylaxis or even serious hypersensitivity involving MDMA in the indexed medical literature. Since there is no similar case in the literature, we thought it was important to report it.

References

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.